DUBLIN - (Business Wire) Research and Markets (http://www.researchandmarkets.com/research/1b2b29/intranasal_drug_de) has announced the addition of the "Intranasal Drug Delivery - US Market Trends & Analysis" report to their offering. The US intranasal drug delivery market is witnessing an expansion of therapeutic applications from the delivery of conventional local therapeutic drugs to the delivery of systemic therapeutic drugs. The future of the technology hinges onto the effective exploitation of the fact that the nose offers an en-route that bypasses the blood-brain barrier through the olfactory region. The market also stands enthused by the continuous research and development activities, which are gradually opening up opportunities in new therapeutic areas, such as, osteoporosis, pain management, vitamin B12 deficiency, smoking cessation, migraines, nocturnal enuresis, rheumatoid arthritis, sexual dysfunction, cancer therapy, insulin-dependent diabetes, and epilepsy.
These and other market data and trends are presented in "Intranasal Drug Delivery: US Market Trends & Analysis" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.
Key Topics Covered:
1. Methodology
2. Global Market Overview And Outlook
3. Market Dynamics
4. Product Facts
5. Recent Technological Developments
7. Major Players
8. Market Analytics
Companies Profiled:
- Aegis Therapeutics LLC (USA)
- Alza Corporation (USA)
- AptarGroup, Inc. (USA)
- Archimedes Pharma Limited. (UK)
- AstraZeneca Plc (UK)
- MedImmune, Inc. (USA)
- Bayer Consumer Care (USA)
- Bespak Plc (UK)
- GlaxoSmithKline Plc (UK)
- Intranasal Therapeutics, Inc. (USA)
- Javelin Pharmaceuticals, Inc (USA)
- Kurve Technology, Inc. (USA)
- MDRNA, Inc. (USA)
- Novartis AG (Switzerland)
- OptiNose AS (Norway)
- Pfizer, Inc. (USA)
- Rexam Plc (UK)
- Schering-Plough Corporation (USA)
- Sanofi-Aventis S.A. (France)
- Unigene Laboratories, Inc. (USA)
For more information visit http://www.researchandmarkets.com/research/1b2b29/intranasal_drug_de
Research and Markets
Laura Wood, Senior Manager,
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
